Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Standard Injection in Opioid-Tolerant TKA
NCT02682498Phase 4Completed
- Sponsor
- University of California, Irvine
- Start
- Oct 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of California, Irvine. Primary endpoint: 48 Hour Post-surgical Opioid Use. Started Oct 2013; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02682498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02682498.